Who should be referred for tricuspid valve intervention?

Abstract

Tricuspid regurgitation (TR) is a common condition that becomes more prevalent with age. Increasing severity of TR is linked to a poorer prognosis. Traditionally, surgery has been the primary treatment option, though outcomes have often been suboptimal. Recently, there has been growing interest in transcatheter interventions for TR, with a range of devices currently under development. These devices generally fall into three categories: valve repair, valve replacement and caval valve implantation. This article explores these various approaches and devices, offering insights into optimal patient selection to maximize therapeutic benefits.